INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,500 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$160K
205 sh
Feb 9, 2026
Page 1345 of 1813
← PrevNext →
Feb 11, 2026
traded Feb 9, 2026
+2d
SEC Form 4

Evidence

3
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
2,756 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$785
1 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$29K
37 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
2,500 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$20K
26 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
1,076 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
53 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$16K
20 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,958 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
8,374 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
2,520 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
AE
Apostolides James EChief Infra & Performance Ofcr
BKRBaker Hughes Co
Option exercise · 10b5-1 plan
M—
11.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

0
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$42K
2,471 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
2,520 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$35K
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,471 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,958 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

59
SA
Sacks Anelise AngelinoDirector
RALRalliant Corp
Open-market purchase
BUY$83K
2,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

44
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Open-market sale
SELL$2.36M
12.0K sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

43
CC
Canuso Dominic CEVP & Chief Financial Officer
TBBKBancorp, Inc.
Open-market purchase
BUY$50K
800 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

43
HH
Hussain HamidPRESIDENT OF THE BANK
BANCBANC OF CALIFORNIA, INC.
Open-market purchase
BUY$296K
14.0K sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

42
CC
Canuso Dominic CEVP & Chief Financial Officer
TBBKBancorp, Inc.
Open-market purchase
BUY$121K
2,000 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

39
CC
Canuso Dominic CEVP & Chief Financial Officer
TBBKBancorp, Inc.
Open-market purchase
BUY$12K
200 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

38
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise
M$316K
53.7K sh
Oct 7, 2025Feb 10, 2026
traded Oct 7, 2025
+126dSEC Form 4

Evidence

35
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Open-market sale
SELL$541K
5,118 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

31
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Open-market sale
SELL$521K
5,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

30
AL
Alvarado LuaniChief People Officer
KVUEKenvue Inc.
Option exercise
M$1.18M
85.5K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

30
ST
Schmid TimothyEVP, WW Chair, MedTech
JNJJOHNSON & JOHNSON
Option exercise
M$1.59M
15.6K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

30
WT
Wong TonySenior Managing Director
IVZInvesco Ltd.
Tax withholding
F$1.08M
40.1K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

30
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Tax withholding
F$5.61M
66.5K sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC Form 4

Evidence

30
ST
Schmid TimothyEVP, WW Chair, MedTech
JNJJOHNSON & JOHNSON
Tax withholding
F$2.48M
10.3K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

26
HM
Havens Thomas M.President, Global FMS
RRYDER SYSTEM INC
Tax withholding
F$1.61M
7,422 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

24
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise
M—
53.7K sh
Oct 7, 2025Feb 10, 2026
traded Oct 7, 2025
+126dSEC Form 4

Evidence

24
JI
Jeddi ImanSVP & GM da Vinci Platforms &
ISRGINTUITIVE SURGICAL INC
Tax withholding
F$152K
309 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

23
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Tax withholding
F$885K
10.5K sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC Form 4

Evidence

23
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Tax withholding
F$540K
6,407 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence